Meningitis

Showing the single result

  • Ventura

    Meningitis Study

    This clinical trial is being conducted to evaluate the safety and immunogenicity of a Meningococcal vaccine in infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine and other recommended routine infant vaccines (RIV). Criteria & Qualifications: • Males and Females in good general health.
    • Must be 6 weeks to 12 weeks old. Compensation: Contact us for more information

    Read more